[Low-intensity laser therapy in pediatric oncology].
Application of low-intensity laser radiotherapy (LILR) allowed to cut down time needed for management of radiation injury and chemotherapy complications in pediatric patients 1.5-2-fold. It was shown that exposure to LIILR caused mononuclear (MN) levels of donors' blood to rise which in turn led to release, in higher concentrations, of IL-1 and FNO cytokins, major factors of immune response development.
Balakirev
S A
SA
Research Institute of Pediatric Oncology and Hematology, N.N. Blokhin Center for Oncology Research, Russian Academy of Medical Sciences, Moscow.
Gusev
L I
LI
Kazanova
M B
MB
Kiselevskiĭ
M V
MV
Grabovshchiner
A Ia
AIa
D002648:Child; D002675:Child, Preschool; D016207:Cytokines / Q000378:metabolism; D006801:Humans; D053685:Laser Therapy; D009369:Neoplasms / Q000276:immunology / Q000532:radiotherapy*
D016207:Cytokines